首页> 外文会议>Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases II >Development of in-vitro models to elucidate mechanisms of intrinsic cellular and tissue fluorescence
【24h】

Development of in-vitro models to elucidate mechanisms of intrinsic cellular and tissue fluorescence

机译:建立体外模型以阐明内在细胞和组织荧光的机制

获取原文

摘要

Abstract: In vitro cell model systems have been used to study the mechanisms of intrinsic cellular and tissue fluorescence as a potential biomarker for cancer. Phenotypic characteristics of cancer that are different from normal tissue include changes in histoarchitecture, proliferation rates and differentiation. a nitrosmethlybenzylamine (NMBA)/rat esophageal carcinogenesis model (NMBA), a transforming growth factor beta (TGF- $beta@)ormal epithelial cell model, and a retinoic acid (RA)/multicellular tumor spheroid model (RAMTS) were used to assess fluorescence changes associated respectively with changes in histoarchitecture, proliferation rates and differentiation. A xenon based fluorescence spectrophotometer (Mediscience Corp.) was used to collect excitation and emission spectra. Two excitation scans ($lambda@Ex 200-360 nm, $lambda@Em 380 nm; $lambda@Ex 240-430 nm, $lambda@Em 450 nm) and two emission scans ($lambda@Ex 300 nm, $lambda@Em 320-580 nm; $lambda@Ex 340 nm, $lambda@Em 360-660 nm) were used to analyze the three model systems. Using the NMBA model. Differences were seen in the excitation scan ($lambda@Ex 200-360 nm, $lambda@Em 380 nm) and the emission scan ($lambda@Ex 340 nm, $lambda@Em 360-660 nm) when normal rat esophageal tissue was compared to hyperplastic and tumor tissue. In the (TGF-$beta@) model, differences were seen in the excitation scan ($lambda@Ex 240-430 nm, $lambda@Em 450 nm) when comparing proliferation slowed (TGF-$beta treated) epithelial cells to their untreated controls. In the RAMTS model, differences were seen with all four scans when RA treated multicellular tumor spheroids (nondifferentiating) were compared to untreated control cells (differentiating). The data indicate that fluorescence changes seen in these model systems may relate to changes in histoarchitecture, proliferation rates and differentiation. Their relationship to in vivo fluorescence changes seen in cancer patients remains to be elucidated.!19
机译:摘要:在体外细胞模型系统中已被用于研究本型细胞和组织荧光作为癌症潜在生物标志物的机制。与正常组织不同的癌症的表型特征包括组织建筑,增殖速率和分化的变化。使用亚硝基甲胺苄胺(NMBA)/大鼠食管癌致癌模型(NMBA),转化生长因子β(TGF-$β)/正常上皮细胞模型,以及视黄酸(RA)/多细胞肿瘤球状体型(RAMT)评估分别与组织建筑,增殖速率和分化的变化相关的荧光变化。基于氙的荧光分光光度计(Mediscience Corp.)用于收集激发和发射光谱。两个激励扫描($ lambda @ ex 200-360 nm,$ lambda @ em 380 nm; $ lambda @ ex 240-430 nm,$ lambda @ em 450 nm)和两个排放扫描($ lambda @ ex 300 nm,$ lambda @EM 320-580 nm; $ lambda @ ex 340 nm,$ lambda @ em 360-660nm)用于分析三种模型系统。使用NMBA模型。在正常大鼠食管组织时,激发扫描($ Lambda @ EX 200-360 NM,$ Lambda @ EX 200-360 NM,$ Lambda @ EX 340 NM,$ Lambda @ EM 360-660nm)中看到了差异与增生和肿瘤组织进行比较。在(TGF-$ BETA @)模型中,在比较增殖(TGF-$β处理)上皮细胞到其上的增殖时,在激发扫描($ lambda @ ex 240-430 nm,$ lambda @ em 450nm)中看到了差异未经处理的控制。在RAMTS模型中,当RA处理的多细胞肿瘤球体(非异化)与未处理的对照细胞进行比较时,所有四次扫描都会看到差异(分化)。数据表明,这些模型系统中看到的荧光变化可以涉及组织建筑,增殖速率和分化的变化。他们在癌症患者中看到的体内荧光变化的关系仍有待阐明。!19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号